Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
Add more filters










Publication year range
1.
CRISPR J ; 6(3): 261-277, 2023 06.
Article in English | MEDLINE | ID: mdl-37272861

ABSTRACT

Type II Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 nucleases have been extensively used in biotechnology and therapeutics. However, many applications are not possible owing to the size, targetability, and potential off-target effects associated with currently known systems. In this study, we identified thousands of CRISPR type II effectors by mining an extensive, genome-resolved metagenomics database encompassing hundreds of thousands of microbial genomes. We developed a high-throughput pipeline that enabled us to predict tracrRNA sequences, to design single guide RNAs, and to demonstrate nuclease activity in vitro for 41 newly described subgroups. Active systems represent an extensive diversity of protein sequences and guide RNA structures and require diverse protospacer adjacent motifs (PAMs) that collectively expand the known targeting capability of current systems. Several nucleases showed activity levels comparable to or significantly higher than SpCas9, despite being smaller in size. In addition, top systems exhibited low levels of off-target editing in mammalian cells, and PAM-interacting domain engineered chimeras further expanded their targetability. These newly discovered nucleases are attractive enzymes for translation into many applications, including therapeutics.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Animals , CRISPR-Cas Systems/genetics , CRISPR-Associated Protein 9/genetics , CRISPR-Associated Protein 9/metabolism , Biotechnology , RNA, Guide, CRISPR-Cas Systems , Mammals/genetics , Mammals/metabolism
2.
CRISPR J ; 6(3): 243-260, 2023 06.
Article in English | MEDLINE | ID: mdl-37219969

ABSTRACT

Development of medicines using gene editing has been hampered by enzymological and immunological impediments. We described previously the discovery and characterization of improved, novel gene-editing systems from metagenomic data. In this study, we substantially advance this work with three such gene-editing systems, demonstrating their utility for cell therapy development. All three systems are capable of reproducible, high-frequency gene editing in primary immune cells. In human T cells, disruption of the T cell receptor (TCR) alpha-chain was induced in >95% of cells, both paralogs of the TCR beta-chain in >90% of cells, and >90% knockout of ß2-microglobulin, TIGIT, FAS, and PDCD1. Simultaneous double knockout of TRAC and TRBC was obtained at a frequency equal to that of the single edits. Gene editing with our systems had minimal effect on T cell viability. Furthermore, we integrate a chimeric antigen receptor (CAR) construct into TRAC (up to ∼60% of T cells), and demonstrate CAR expression and cytotoxicity. We next applied our novel gene-editing tools to natural killer (NK) cells, B cells, hematopoietic stem cells, and induced pluripotent stem cells, generating similarly efficient cell-engineering outcomes including the creation of active CAR-NK cells. Interrogation of our gene-editing systems' specificity reveals a profile comparable with or better than Cas9. Finally, our nucleases lack preexisting humoral and T cell-based immunity, consistent with their sourcing from nonhuman pathogens. In all, we show these new gene-editing systems have the activity, specificity, and translatability necessary for use in cell therapy development.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Humans , CRISPR-Cas Systems/genetics , T-Lymphocytes/metabolism , Cell Differentiation , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/metabolism
3.
Hepatol Commun ; 7(3): e0070, 2023 03 01.
Article in English | MEDLINE | ID: mdl-36848094

ABSTRACT

BACKGROUND: α1-antitrypsin deficiency is most commonly caused by a mutation in exon-7 of SERPINA1 (SA1-ATZ), resulting in hepatocellular accumulation of a misfolded variant (ATZ). Human SA1-ATZ-transgenic (PiZ) mice exhibit hepatocellular ATZ accumulation and liver fibrosis. We hypothesized that disrupting the SA1-ATZ transgene in PiZ mice by in vivo genome editing would confer a proliferative advantage to the genome-edited hepatocytes, enabling them to repopulate the liver. METHODS: To create a targeted DNA break in exon-7 of the SA1-ATZ transgene, we generated 2 recombinant adeno-associated viruses (rAAV) expressing a zinc-finger nuclease pair (rAAV-ZFN), and another rAAV for gene correction by targeted insertion (rAAV-TI). PiZ mice were injected i.v. with rAAV-TI alone or the rAAV-ZFNs at a low (7.5×1010vg/mouse, LD) or a high dose (1.5×1011vg/mouse, HD), with or without rAAV-TI. Two weeks and 6 months after treatment, livers were harvested for molecular, histological, and biochemical analyses. RESULTS: Two weeks after treatment, deep sequencing of the hepatic SA1-ATZ transgene pool showed 6%±3% or 15%±4% nonhomologous end joining in mice receiving LD or HD rAAV-ZFN, respectively, which increased to 36%±12% and 36%±12%, respectively, 6 months after treatment. Two weeks postinjection of rAAV-TI with LD or HD of rAAV-ZFN, repair by targeted insertion occurred in 0.10%±0.09% and 0.25%±0.14% of SA1-ATZ transgenes, respectively, which increased to 5.2%±5.0% and 33%±13%, respectively, 6 months after treatment. Six months after rAAV-ZFN administration, there was a marked clearance of ATZ globules from hepatocytes, and resolution of liver fibrosis, along with reduction of hepatic TAZ/WWTR1, hedgehog ligands, Gli2, a TIMP, and collagen content. CONCLUSIONS: ZFN-mediated SA1-ATZ transgene disruption provides a proliferative advantage to ATZ-depleted hepatocytes, enabling them to repopulate the liver and reverse hepatic fibrosis.


Subject(s)
Gene Editing , Zinc Finger Nucleases , Humans , Animals , Mice , Liver Cirrhosis/genetics , Liver Cirrhosis/therapy , Hepatocytes , Disease Models, Animal , Intracellular Signaling Peptides and Proteins
4.
Nat Commun ; 13(1): 7602, 2022 12 15.
Article in English | MEDLINE | ID: mdl-36522342

ABSTRACT

Programmable, RNA-guided nucleases are diverse enzymes that have been repurposed for biotechnological applications. However, to further expand the therapeutic application of these tools there is a need for targetable systems that are small enough to be delivered efficiently. Here, we mined an extensive genome-resolved metagenomics database and identified families of uncharacterized RNA-guided, compact nucleases (between 450 and 1,050 aa). We report that Cas9d, a new CRISPR type II subtype, contains Zinc-finger motifs and high arginine content, features that we also found in nucleases related to HEARO effectors. These enzymes exhibit diverse biochemical characteristics and are broadly targetable. We show that natural Cas9d enzymes are capable of genome editing in mammalian cells with >90% efficiency, and further engineered nickase variants into the smallest base editors active in E. coli and human cells. Their small size, broad targeting potential, and translatability suggest that Cas9d and HEARO systems will enable a variety of genome editing applications.


Subject(s)
Escherichia coli , Gene Editing , Animals , Humans , Escherichia coli/genetics , Escherichia coli/metabolism , Endonucleases/genetics , Endonucleases/metabolism , Clustered Regularly Interspaced Short Palindromic Repeats , Ribonucleases/genetics , RNA , CRISPR-Cas Systems/genetics , Mammals/genetics
5.
Curr Protoc Stem Cell Biol ; 36: 5B.4.1-5B.4.10, 2016 Feb 03.
Article in English | MEDLINE | ID: mdl-26840227

ABSTRACT

This unit describes the protocol for the delivery of reagents for targeted genome editing to CD34(+) hematopoietic stem/progenitor cells (HSPCs). Specifically, this unit focuses on the process of thawing and pre-stimulating CD34(+) HSPCs, as well as the details of their electroporation with in vitro-transcribed mRNA-encoding site-specific nucleases [in this case zinc-finger nucleases (ZFNs)]. In addition, discussed is delivery of a gene editing donor template in the form of an oligonucleotide or integrase-defective lentiviral vector (IDLV). Finally, an analysis of cell survival following treatment and downstream culture conditions are presented. While optimization steps might be needed for each specific application with respect to nuclease and donor template amount, adherence to this protocol will serve as an excellent starting point for this further work.


Subject(s)
Drug Delivery Systems/methods , Electroporation/methods , Genome, Human , Hematopoietic Stem Cells , Lentivirus , Transduction, Genetic/methods , Animals , Antigens, CD34 , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Humans
6.
Blood ; 125(17): 2597-604, 2015 Apr 23.
Article in English | MEDLINE | ID: mdl-25733580

ABSTRACT

Sickle cell disease (SCD) is characterized by a single point mutation in the seventh codon of the ß-globin gene. Site-specific correction of the sickle mutation in hematopoietic stem cells would allow for permanent production of normal red blood cells. Using zinc-finger nucleases (ZFNs) designed to flank the sickle mutation, we demonstrate efficient targeted cleavage at the ß-globin locus with minimal off-target modification. By co-delivering a homologous donor template (either an integrase-defective lentiviral vector or a DNA oligonucleotide), high levels of gene modification were achieved in CD34(+) hematopoietic stem and progenitor cells. Modified cells maintained their ability to engraft NOD/SCID/IL2rγ(null) mice and to produce cells from multiple lineages, although with a reduction in the modification levels relative to the in vitro samples. Importantly, ZFN-driven gene correction in CD34(+) cells from the bone marrow of patients with SCD resulted in the production of wild-type hemoglobin tetramers.


Subject(s)
Anemia, Sickle Cell/genetics , Anemia, Sickle Cell/therapy , Genetic Therapy , Hematopoietic Stem Cells/metabolism , Mutation , beta-Globins/genetics , Anemia, Sickle Cell/pathology , Animals , Antigens, CD34/analysis , Base Sequence , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Cells, Cultured , Endodeoxyribonucleases/metabolism , Fetal Blood/transplantation , Genetic Loci , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/pathology , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Molecular Sequence Data , Zinc Fingers
7.
ACS Chem Biol ; 9(11): 2594-602, 2014 Nov 21.
Article in English | MEDLINE | ID: mdl-25188731

ABSTRACT

Copy number variation resulting in excess PMP22 protein causes the peripheral neuropathy Charcot-Marie-Tooth disease, type 1A. To broadly interrogate chemically sensitive transcriptional pathways controlling PMP22 protein levels, we used the targeting precision of TALEN-mediated genome editing to embed reporters within the genetic locus harboring the Peripheral Myelin Protein 22 (Pmp22) gene. Using a Schwann cell line with constitutively high endogenous levels of Pmp22, we obtained allelic insertion of secreted bioluminescent reporters with sufficient signal to enable a 1536-well assay. Our findings from the quantitative high-throughput screening (qHTS) of several thousand drugs and clinically investigated compounds using this assay design both overlapped and expanded results from a previous assay using a randomly inserted reporter gene controlled by a single regulatory element of the Pmp22 gene. A key difference was the identification of a kinase-controlled inhibitory pathway of Pmp22 transcription revealed by the activity of the Protein kinase C (PKC)-modulator bryostatin.


Subject(s)
Charcot-Marie-Tooth Disease/genetics , Genome, Human , High-Throughput Nucleotide Sequencing , Humans
8.
Genes Dev ; 28(17): 1885-99, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25128433

ABSTRACT

Telomere length homeostasis is essential for the long-term survival of stem cells, and its set point determines the proliferative capacity of differentiated cell lineages by restricting the reservoir of telomeric repeats. Knockdown and overexpression studies in human tumor cells showed that the shelterin subunit TPP1 recruits telomerase to telomeres through a region termed the TEL patch. However, these studies do not resolve whether the TPP1 TEL patch is the only mechanism for telomerase recruitment and whether telomerase regulation studied in tumor cells is representative of nontransformed cells such as stem cells. Using genome engineering of human embryonic stem cells, which have physiological telomere length homeostasis, we establish that the TPP1 TEL patch is genetically essential for telomere elongation and thus long-term cell viability. Furthermore, genetic bypass, protein fusion, and intragenic complementation assays define two distinct additional mechanisms of TPP1 involvement in telomerase action at telomeres. We demonstrate that TPP1 provides an essential step of telomerase activation as well as feedback regulation of telomerase by telomere length, which is necessary to determine the appropriate telomere length set point in human embryonic stem cells. These studies reveal and resolve multiple TPP1 roles in telomere elongation and stem cell telomere length homeostasis.


Subject(s)
Telomerase/metabolism , Telomere Homeostasis/genetics , Telomere/enzymology , Embryonic Stem Cells , Enzyme Activation/genetics , Gene Knockout Techniques , Genetic Complementation Test , Humans , Proto-Oncogene Proteins c-ets/genetics , Proto-Oncogene Proteins c-ets/metabolism , Repressor Proteins/genetics , Repressor Proteins/metabolism , Shelterin Complex , Telomerase/genetics , Telomere/genetics , Telomere-Binding Proteins/genetics , Telomere-Binding Proteins/metabolism , ETS Translocation Variant 6 Protein
9.
Genome Res ; 24(8): 1371-83, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24989021

ABSTRACT

The generation of genetically modified animals is important for both research and commercial purposes. The rat is an important model organism that until recently lacked efficient genetic engineering tools. Sequence-specific nucleases, such as ZFNs, TALE nucleases, and CRISPR/Cas9 have allowed the creation of rat knockout models. Genetic engineering by homology-directed repair (HDR) is utilized to create animals expressing transgenes in a controlled way and to introduce precise genetic modifications. We applied TALE nucleases and donor DNA microinjection into zygotes to generate HDR-modified rats with large new sequences introduced into three different loci with high efficiency (0.62%-5.13% of microinjected zygotes). Two of these loci (Rosa26 and Hprt1) are known to allow robust and reproducible transgene expression and were targeted for integration of a GFP expression cassette driven by the CAG promoter. GFP-expressing embryos and four Rosa26 GFP rat lines analyzed showed strong and widespread GFP expression in most cells of all analyzed tissues. The third targeted locus was Ighm, where we performed successful exon exchange of rat exon 2 for the human one. At all three loci we observed HDR only when using linear and not circular donor DNA. Mild hypothermic (30°C) culture of zygotes after microinjection increased HDR efficiency for some loci. Our study demonstrates that TALE nuclease and donor DNA microinjection into rat zygotes results in efficient and reproducible targeted donor integration by HDR. This allowed creation of genetically modified rats in a work-, cost-, and time-effective manner.


Subject(s)
Gene Targeting , Genetic Engineering , Animals , Base Sequence , Cells, Cultured , DNA Restriction Enzymes/biosynthesis , DNA Restriction Enzymes/genetics , Female , Hypoxanthine Phosphoribosyltransferase/genetics , Male , Microinjections , Rats, Sprague-Dawley , Rats, Transgenic , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinational DNA Repair , Zygote
10.
Stem Cell Reports ; 2(6): 838-52, 2014 Jun 03.
Article in English | MEDLINE | ID: mdl-24936470

ABSTRACT

Genetically engineered human pluripotent stem cells (hPSCs) have been proposed as a source for transplantation therapies and are rapidly becoming valuable tools for human disease modeling. However, many applications are limited due to the lack of robust differentiation paradigms that allow for the isolation of defined functional tissues. Here, using an endogenous LGR5-GFP reporter, we derived adult stem cells from hPSCs that gave rise to functional human intestinal tissue comprising all major cell types of the intestine. Histological and functional analyses revealed that such human organoid cultures could be derived with high purity and with a composition and morphology similar to those of cultures obtained from human biopsies. Importantly, hPSC-derived organoids responded to the canonical signaling pathways that control self-renewal and differentiation in the adult human intestinal stem cell compartment. This adult stem cell system provides a platform for studying human intestinal disease in vitro using genetically engineered hPSCs.


Subject(s)
Adult Stem Cells/cytology , Adult Stem Cells/metabolism , Gene Expression Profiling/methods , Intestines/cytology , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Cells, Cultured , Humans , Receptors, G-Protein-Coupled/metabolism
11.
Nature ; 500(7462): 296-300, 2013 Aug 15.
Article in English | MEDLINE | ID: mdl-23863942

ABSTRACT

Down's syndrome is a common disorder with enormous medical and social costs, caused by trisomy for chromosome 21. We tested the concept that gene imbalance across an extra chromosome can be de facto corrected by manipulating a single gene, XIST (the X-inactivation gene). Using genome editing with zinc finger nucleases, we inserted a large, inducible XIST transgene into the DYRK1A locus on chromosome 21, in Down's syndrome pluripotent stem cells. The XIST non-coding RNA coats chromosome 21 and triggers stable heterochromatin modifications, chromosome-wide transcriptional silencing and DNA methylation to form a 'chromosome 21 Barr body'. This provides a model to study human chromosome inactivation and creates a system to investigate genomic expression changes and cellular pathologies of trisomy 21, free from genetic and epigenetic noise. Notably, deficits in proliferation and neural rosette formation are rapidly reversed upon silencing one chromosome 21. Successful trisomy silencing in vitro also surmounts the major first step towards potential development of 'chromosome therapy'.


Subject(s)
Chromosomes, Human, Pair 21/genetics , Dosage Compensation, Genetic , Down Syndrome/genetics , RNA, Long Noncoding/metabolism , Animals , Cell Line , Cell Proliferation , DNA Methylation , Down Syndrome/therapy , Gene Silencing , Humans , Induced Pluripotent Stem Cells , Male , Mice , Mutagenesis, Insertional , Neurogenesis , RNA, Long Noncoding/genetics , Sex Chromatin/genetics , X Chromosome Inactivation/genetics
12.
Biotechnol Bioeng ; 110(3): 871-80, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23042119

ABSTRACT

Targeted DNA integration is commonly used to eliminate position effects on transgene expression. Integration can be targeted to specific sites in the genome via both homology-based and homology-independent processes. Both pathways start the integration process with a site-specific break in the chromosome, typically from a zinc-finger nuclease (ZFN). We previously described an efficient homology-independent targeted integration technique that captures short (<100 bp) pieces of DNA at chromosomal breaks created by ZFNs. We show here that inclusion of a nuclease target site on the donor plasmid followed by in vivo nuclease cleavage of both the donor and the chromosome results in efficient integration of large, transgene-sized DNA molecules into the chromosomal double-strand break. Successful targeted integration via in vivo donor linearization is demonstrated at five distinct loci in two mammalian cell types, highlighting the generality of the approach. Finally, we show that CHO cells, a cell type recalcitrant to homology-based integration, are proficient at capture of in vivo-linearized transgene donors. Moreover, we demonstrate knockout of the hamster FUT8 gene via the simultaneous ZFN- or TALE nuclease-mediated integration of an antibody cassette. Our results enable efficient targeted transgene addition to cells and organisms that fare poorly with traditional homology-driven approaches.


Subject(s)
Chromosomes/metabolism , DNA, Circular/metabolism , Deoxyribonucleases/metabolism , Gene Targeting , Plasmids/metabolism , Recombination, Genetic , Transgenes , Animals , Cell Line , DNA, Circular/genetics , Humans , Mutagenesis, Insertional
14.
Proc Natl Acad Sci U S A ; 108(29): 12013-7, 2011 Jul 19.
Article in English | MEDLINE | ID: mdl-21730124

ABSTRACT

Zinc-finger nucleases (ZFNs) are powerful tools for producing gene knockouts (KOs) with high efficiency. Whereas ZFN-mediated gene disruption has been demonstrated in laboratory animals such as mice, rats, and fruit flies, ZFNs have not been used to disrupt an endogenous gene in any large domestic species. Here we used ZFNs to induce a biallelic knockout of the porcine α1,3-galactosyltransferase (GGTA1) gene. Primary porcine fibroblasts were treated with ZFNs designed against the region coding for the catalytic core of GGTA1, resulting in biallelic knockout of ∼1% of ZFN-treated cells. A galactose (Gal) epitope counter-selected population of these cells was used in somatic cell nuclear transfer (SCNT). Of the resulting six fetuses, all completely lacked Gal epitopes and were phenotypically indistinguishable from the starting donor cell population, illustrating that ZFN-mediated genetic modification did not interfere with the cloning process. Neither off-target cleavage events nor integration of the ZFN-coding plasmid was detected. The GGTA1-KO phenotype was confirmed by a complement lysis assay that demonstrated protection of GGTA1-KO fibroblasts relative to wild-type cells. Cells from GGTA1-KO fetuses and pooled, transfected cells were used to produce live offspring via SCNT. This study reports the production of cloned pigs carrying a biallelic ZFN-induced knockout of an endogenous gene. These findings open a unique avenue toward the creation of gene KO pigs, which could benefit both agriculture and biomedicine.


Subject(s)
Cloning, Organism/methods , Deoxyribonucleases/metabolism , Galactosyltransferases/genetics , Gene Knockout Techniques/methods , Sus scrofa/genetics , Animals , Base Sequence , DNA Primers/genetics , Fibroblasts , Flow Cytometry , Molecular Sequence Data , Nuclear Transfer Techniques , Sequence Analysis, DNA , Transplantation, Heterologous/methods
15.
Nat Biotechnol ; 29(8): 731-4, 2011 Jul 07.
Article in English | MEDLINE | ID: mdl-21738127

ABSTRACT

Targeted genetic engineering of human pluripotent cells is a prerequisite for exploiting their full potential. Such genetic manipulations can be achieved using site-specific nucleases. Here we engineered transcription activator-like effector nucleases (TALENs) for five distinct genomic loci. At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).


Subject(s)
Embryonic Stem Cells/physiology , Endonucleases/metabolism , Gene Targeting/methods , Genetic Engineering/methods , Induced Pluripotent Stem Cells/physiology , Transcription Factors/metabolism , Base Sequence , Endonucleases/genetics , Homeodomain Proteins/genetics , Humans , Molecular Sequence Data , Myosin-Light-Chain Phosphatase/genetics , Octamer Transcription Factor-3/genetics , Transcription Factors/genetics , Zinc Fingers
16.
PLoS One ; 6(2): e16961, 2011 Feb 08.
Article in English | MEDLINE | ID: mdl-21347446

ABSTRACT

Sequences governing RNA splicing are difficult to study in situ due to the great difficulty of traditional targeted mutagenesis. Zinc-finger nuclease (ZFN) technology allows for the rapid and efficient introduction of site-specific mutations into mammalian chromosomes. Using a ZFN pair along with a donor plasmid to manipulate the outcomes of DNA repair, we introduced several discrete, targeted mutations into the fourth intron of the endogenous BAX gene in Chinese hamster ovary cells. Putative lariat branch points, the polypyrimidine tract, and the splice acceptor site were targeted. We recovered numerous otherwise isogenic clones carrying the intended mutations and analyzed the effect of each on BAX pre-mRNA splicing. Mutation of one of three possible branch points, the polypyrimidine tract, and the splice acceptor site all caused exclusion of exon five from BAX mRNA. Interestingly, these exon-skipping mutations allowed usage of cryptic splice acceptor sites within intron four. These data demonstrate that ZFN-mediated gene editing is a highly effective tool for dissection of pre-mRNA splicing regulatory sequences in their endogenous context.


Subject(s)
Genetic Loci/genetics , RNA Splicing/genetics , Ribonucleases/chemistry , Ribonucleases/metabolism , Zinc Fingers , Animals , Base Sequence , CHO Cells , Cricetinae , Cricetulus , Mutagenesis , RNA Splice Sites/genetics , Ribonucleases/genetics , bcl-2-Associated X Protein/genetics
17.
Nat Biotechnol ; 29(2): 143-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21179091

ABSTRACT

Nucleases that cleave unique genomic sequences in living cells can be used for targeted gene editing and mutagenesis. Here we develop a strategy for generating such reagents based on transcription activator-like effector (TALE) proteins from Xanthomonas. We identify TALE truncation variants that efficiently cleave DNA when linked to the catalytic domain of FokI and use these nucleases to generate discrete edits or small deletions within endogenous human NTF3 and CCR5 genes at efficiencies of up to 25%. We further show that designed TALEs can regulate endogenous mammalian genes. These studies demonstrate the effective application of designed TALE transcription factors and nucleases for the targeted regulation and modification of endogenous genes.


Subject(s)
Combinatorial Chemistry Techniques/methods , Genetic Engineering , Mutagenesis, Site-Directed/methods , Transcription Factors/genetics , Transcription Factors/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Base Sequence , Binding Sites , DNA/genetics , DNA/metabolism , Deoxyribonucleases, Type II Site-Specific/genetics , Deoxyribonucleases, Type II Site-Specific/metabolism , Genome , Humans , K562 Cells , Molecular Sequence Data , Receptors, CCR5/genetics , Vascular Endothelial Growth Factor A/genetics , Xanthomonas
18.
Eur J Immunol ; 40(10): 2932-41, 2010 Oct.
Article in English | MEDLINE | ID: mdl-21038471

ABSTRACT

The rat is a species frequently used in immunological studies but, until now, there were no models with introduced gene-specific mutations. In a recent study, we described for the first time the generation of novel rat lines with targeted mutations using zinc-finger nucleases. In this study, we compare immune development in two Ig heavy-chain KO lines; one with truncated Cµ and a new line with removed JH segments. Rats homozygous for IgM mutation generate truncated Cµ mRNA with a de novo stop codon and no Cγ mRNA. JH-deletion rats showed undetectable mRNA for all H-chain transcripts. No serum IgM, IgG, IgA and IgE were detected in these rat lines. In both lines, lymphoid B-cell numbers were reduced >95% versus WT animals. In rats homozygous for IgM mutation, no Ab-mediated hyperacute allograft rejection was encountered. Similarities in B-cell differentiation seen in Ig KO rats and ES cell-derived Ig KO mice are discussed. These Ig and B-cell-deficient rats obtained using zinc-finger nucleases-technology should be useful as biomedical research models and a powerful platform for transgenic animals expressing a human Ab repertoire.


Subject(s)
B-Lymphocytes/immunology , Heart Transplantation/immunology , Immunoglobulin Constant Regions/immunology , Immunoglobulin Heavy Chains/immunology , Immunoglobulin Joining Region/immunology , Amino Acid Sequence , Animals , Animals, Genetically Modified , B-Lymphocytes/cytology , Cell Differentiation/immunology , Embryonic Stem Cells/immunology , Graft Survival/immunology , Immunoglobulin Constant Regions/genetics , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Isotypes/blood , Immunoglobulin Joining Region/genetics , Lymphoid Tissue/immunology , Molecular Sequence Data , RNA/chemistry , RNA/genetics , Rats , Rats, Inbred Lew , Rats, Mutant Strains , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Specific Pathogen-Free Organisms , Zinc Fingers/genetics
19.
Biotechnol Bioeng ; 106(5): 774-83, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-20564614

ABSTRACT

IgG1 antibodies produced in Chinese hamster ovary (CHO) cells are heavily alpha1,6-fucosylated, a modification that reduces antibody-dependent cellular cytotoxicity (ADCC) and can inhibit therapeutic antibody function in vivo. Addition of fucose is catalyzed by Fut8, a alpha1,6-fucosyltransferase. FUT8(-/-) CHO cell lines produce completely nonfucosylated antibodies, but the difficulty of recapitulating the knockout in protein-production cell lines has prevented the widespread adoption of FUT8(-/-) cells as hosts for antibody production. We have created zinc-finger nucleases (ZFNs) that cleave the FUT8 gene in a region encoding the catalytic core of the enzyme, allowing the functional disruption of FUT8 in any CHO cell line. These reagents produce FUT8(-/-) CHO cells in 3 weeks at a frequency of 5% in the absence of any selection. Alternately, populations of ZFN-treated cells can be directly selected to give FUT8(-/-) cell pools in as few as 3 days. To demonstrate the utility of this method in bioprocess, FUT8 was disrupted in a CHO cell line used for stable protein production. ZFN-derived FUT8(-/-) cell lines were as transfectable as wild-type, had similar or better growth profiles, and produced equivalent amounts of antibody during transient transfection. Antibodies made in these lines completely lacked core fucosylation but had an otherwise normal glycosylation pattern. Cell lines stably expressing a model antibody were made from wild-type and ZFN-generated FUT8(-/-) cells. Clones from both lines had equivalent titer, specific productivity distributions, and integrated viable cell counts. Antibody titer in the best ZFN-generated FUT8(-/-) cell lines was fourfold higher than in the best-producing clones of FUT8(-/-) cells made by standard homologous recombination in a different CHO subtype. These data demonstrate the straightforward, ZFN-mediated transfer of the Fut8- phenotype to a production CHO cell line without adverse phenotypic effects. This process will speed the production of highly active, completely nonfucosylated therapeutic antibodies.


Subject(s)
DNA/metabolism , Deoxyribonucleases/metabolism , Fucosyltransferases/genetics , Gene Deletion , Genetic Techniques , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/chemistry , Biotechnology/methods , CHO Cells , Cell Culture Techniques , Cricetinae , Cricetulus , Zinc Fingers
20.
Nucleic Acids Res ; 38(15): e152, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20530528

ABSTRACT

We previously demonstrated high-frequency, targeted DNA addition mediated by the homology-directed DNA repair pathway. This method uses a zinc-finger nuclease (ZFN) to create a site-specific double-strand break (DSB) that facilitates copying of genetic information into the chromosome from an exogenous donor molecule. Such donors typically contain two approximately 750 bp regions of chromosomal sequence required for homology-directed DNA repair. Here, we demonstrate that easily-generated linear donors with extremely short (50 bp) homology regions drive transgene integration into 5-10% of chromosomes. Moreover, we measure the overhangs produced by ZFN cleavage and find that oligonucleotide donors with single-stranded 5' overhangs complementary to those made by ZFNs are efficiently ligated in vivo to the DSB. Greater than 10% of all chromosomes directly incorporate this exogenous DNA via a process that is dependent upon and guided by complementary 5' overhangs on the donor DNA. Finally, we extend this non-homologous end-joining (NHEJ)-based technique by directly inserting donor DNA comprising recombinase sites into large deletions created by the simultaneous action of two separate ZFN pairs. Up to 50% of deletions contained a donor insertion. Targeted DNA addition via NHEJ complements our homology-directed targeted integration approaches, adding versatility to the manipulation of mammalian genomes.


Subject(s)
Deoxyribonucleases, Type II Site-Specific/metabolism , Gene Targeting/methods , Zinc Fingers , Animals , CHO Cells , Chromosomes, Mammalian/chemistry , Cricetinae , Cricetulus , DNA/chemistry , DNA Breaks, Double-Stranded , Deoxyribonucleases, Type II Site-Specific/chemistry , Genome , Humans , K562 Cells , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...